Piper Sandler analyst Jason Bednar maintained a Hold rating on Masimo (MASI – Research Report) today and set a price target of $126.00. The company’s shares closed yesterday at $136.00.
Bednar covers the Healthcare sector, focusing on stocks such as Align Tech, Cooper Co, and Masimo. According to TipRanks, Bednar has an average return of -4.8% and a 40.60% success rate on recommended stocks.
In addition to Piper Sandler, Masimo also received a Hold from Needham’s Michael Matson in a report issued today. However, yesterday, BTIG reiterated a Buy rating on Masimo (NASDAQ: MASI).
Based on Masimo’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $478.9 million and a net profit of $10.6 million. In comparison, last year the company earned a revenue of $549.3 million and had a net profit of $37.9 million
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Masimo (MASI) Company Description:
Masimo Corp. is a medical technology company, which develops, manufactures and markets non invasive patient monitoring technologies, medical devices and sensors. Its products include continuous monitors, patient-worn monitors, hospital automation connectivity, capnography & gas, data download & analytics and sensors & accessories. The company was founded by Joe E. Kiani in May 1989 and is headquartered in Irvine, CA.
